EXCITING CANCER RESEARCH FROM JOHNS HOPKINS

post-img

A new medication is under research that is having significant impact on a variety of cancers. This medication, still without a name, is in a group of medicines that block a protein called PD-1. In a recent study, early results have been encouraging in lung cancer, melanoma, and kidney cancer. Even at advanced stages, this …